146 related articles for article (PubMed ID: 38174903)
1. Estimation of age of onset and progression of breast cancer by absolute risk dependent on polygenic risk score and other risk factors.
Bhatt R; van den Hout A; Antoniou AC; Shah M; Ficorella L; Steggall E; Easton DF; Pharoah PDP; Pashayan N
Cancer; 2024 May; 130(9):1590-1599. PubMed ID: 38174903
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
[TBL] [Abstract][Full Text] [Related]
3. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
[TBL] [Abstract][Full Text] [Related]
4. Addition of a 161-SNP polygenic risk score to family history-based risk prediction: impact on clinical management in non-
Lakeman IMM; Hilbers FS; Rodríguez-Girondo M; Lee A; Vreeswijk MPG; Hollestelle A; Seynaeve C; Meijers-Heijboer H; Oosterwijk JC; Hoogerbrugge N; Olah E; Vasen HFA; van Asperen CJ; Devilee P
J Med Genet; 2019 Sep; 56(9):581-589. PubMed ID: 31186341
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Inherited Risk Estimation for Risk-Based Breast Cancer Screening in Women.
Mars N; Kerminen S; Tamlander M; Pirinen M; Jakkula E; Aaltonen K; Meretoja T; Heinävaara S; Widén E; Ripatti S;
J Clin Oncol; 2024 May; 42(13):1477-1487. PubMed ID: 38422475
[TBL] [Abstract][Full Text] [Related]
6. Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.
Vachon CM; Scott CG; Tamimi RM; Thompson DJ; Fasching PA; Stone J; Southey MC; Winham S; Lindström S; Lilyquist J; Giles GG; Milne RL; MacInnis RJ; Baglietto L; Li J; Czene K; Bolla MK; Wang Q; Dennis J; Haeberle L; Eriksson M; Kraft P; Luben R; Wareham N; Olson JE; Norman A; Polley EC; Maskarinec G; Le Marchand L; Haiman CA; Hopper JL; Couch FJ; Easton DF; Hall P; Chatterjee N; Garcia-Closas M
Breast Cancer Res; 2019 May; 21(1):68. PubMed ID: 31118087
[TBL] [Abstract][Full Text] [Related]
7. Addition of polygenic risk score to a risk calculator for prediction of breast cancer in US Black women.
Zirpoli GR; Pfeiffer RM; Bertrand KA; Huo D; Lunetta KL; Palmer JR
Breast Cancer Res; 2024 Jan; 26(1):2. PubMed ID: 38167144
[TBL] [Abstract][Full Text] [Related]
8. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
Elife; 2023 Mar; 12():. PubMed ID: 36971353
[TBL] [Abstract][Full Text] [Related]
9. Simplified Breast Risk Tool Integrating Questionnaire Risk Factors, Mammographic Density, and Polygenic Risk Score: Development and Validation.
Rosner B; Tamimi RM; Kraft P; Gao C; Mu Y; Scott C; Winham SJ; Vachon CM; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2021 Apr; 30(4):600-607. PubMed ID: 33277321
[TBL] [Abstract][Full Text] [Related]
10. Validation of a genetic risk score for Arkansas women of color.
Starlard-Davenport A; Allman R; Dite GS; Hopper JL; Spaeth Tuff E; Macleod S; Kadlubar S; Preston M; Henry-Tillman R
PLoS One; 2018; 13(10):e0204834. PubMed ID: 30281645
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
12. Prediction of breast cancer risk based on profiling with common genetic variants.
Mavaddat N; Pharoah PD; Michailidou K; Tyrer J; Brook MN; Bolla MK; Wang Q; Dennis J; Dunning AM; Shah M; Luben R; Brown J; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Czene K; Darabi H; Eriksson M; Peto J; Dos-Santos-Silva I; Dudbridge F; Johnson N; Schmidt MK; Broeks A; Verhoef S; Rutgers EJ; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Figueroa J; Chanock SJ; Brinton L; Lissowska J; Couch FJ; Olson JE; Vachon C; Pankratz VS; Lambrechts D; Wildiers H; Van Ongeval C; van Limbergen E; Kristensen V; Grenaker Alnæs G; Nord S; Borresen-Dale AL; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Fasching PA; Haeberle L; Ekici AB; Beckmann MW; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Trentham-Dietz A; Newcomb P; Titus L; Egan KM; Hunter DJ; Lindstrom S; Tamimi RM; Kraft P; Rahman N; Turnbull C; Renwick A; Seal S; Li J; Liu J; Humphreys K; Benitez J; Pilar Zamora M; Arias Perez JI; Menéndez P; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Bogdanova NV; Antonenkova NN; Dörk T; Anton-Culver H; Neuhausen SL; Ziogas A; Bernstein L; Devilee P; Tollenaar RA; Seynaeve C; van Asperen CJ; Cox A; Cross SS; Reed MW; Khusnutdinova E; Bermisheva M; Prokofyeva D; Takhirova Z; Meindl A; Schmutzler RK; Sutter C; Yang R; Schürmann P; Bremer M; Christiansen H; Park-Simon TW; Hillemanns P; Guénel P; Truong T; Menegaux F; Sanchez M; Radice P; Peterlongo P; Manoukian S; Pensotti V; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Brauch H; Brüning T; Ko YD; Sigurdson AJ; Doody MM; Hamann U; Torres D; Ulmer HU; Försti A; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Andrulis IL; Knight JA; Glendon G; Marie Mulligan A; Chenevix-Trench G; Balleine R; Giles GG; Milne RL; McLean C; Lindblom A; Margolin S; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Eilber U; Wang-Gohrke S; Hooning MJ; Hollestelle A; van den Ouweland AM; Koppert LB; Carpenter J; Clarke C; Scott R; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Brenner H; Arndt V; Stegmaier C; Karina Dieffenbach A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Offit K; Vijai J; Robson M; Rau-Murthy R; Dwek M; Swann R; Annie Perkins K; Goldberg MS; Labrèche F; Dumont M; Eccles DM; Tapper WJ; Rafiq S; John EM; Whittemore AS; Slager S; Yannoukakos D; Toland AE; Yao S; Zheng W; Halverson SL; González-Neira A; Pita G; Rosario Alonso M; Álvarez N; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Ahmed S; Maranian M; Healey CS; Simard J; Hall P; Easton DF; Garcia-Closas M
J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25855707
[TBL] [Abstract][Full Text] [Related]
13. The impact of risk stratification by polygenic risk and age on breast cancer screening in women aged 40-49 years: a modelling study.
Huntley C; Torr B; Sud A; Houlston RS; Hingorani AD; Jones ME; Turnbull C
Lancet; 2023 Nov; 402 Suppl 1():S54. PubMed ID: 37997097
[TBL] [Abstract][Full Text] [Related]
14. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model.
Hung RJ; Warkentin MT; Brhane Y; Chatterjee N; Christiani DC; Landi MT; Caporaso NE; Liu G; Johansson M; Albanes D; Marchand LL; Tardon A; Rennert G; Bojesen SE; Chen C; Field JK; Kiemeney LA; Lazarus P; Zienolddiny S; Lam S; Andrew AS; Arnold SM; Aldrich MC; Bickeböller H; Risch A; Schabath MB; McKay JD; Brennan P; Amos CI
Cancer Res; 2021 Mar; 81(6):1607-1615. PubMed ID: 33472890
[TBL] [Abstract][Full Text] [Related]
15. Integrating a Polygenic Risk Score into a clinical setting would impact risk predictions in familial breast cancer.
Baliakas P; Munters AR; Kämpe A; Tesi B; Bondeson ML; Ladenvall C; Eriksson D
J Med Genet; 2024 Jan; 61(2):150-154. PubMed ID: 37580114
[TBL] [Abstract][Full Text] [Related]
16. [Interest in the use of polygenic risk scores in breast cancer screening and preventive medicine].
Crèvecoeur J; Docampo E; Martin M; Bours V
Rev Med Liege; 2024 Jun; 79(5-6):372-378. PubMed ID: 38869126
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
[TBL] [Abstract][Full Text] [Related]
18. BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.
Lee A; Mavaddat N; Wilcox AN; Cunningham AP; Carver T; Hartley S; Babb de Villiers C; Izquierdo A; Simard J; Schmidt MK; Walter FM; Chatterjee N; Garcia-Closas M; Tischkowitz M; Pharoah P; Easton DF; Antoniou AC
Genet Med; 2019 Aug; 21(8):1708-1718. PubMed ID: 30643217
[TBL] [Abstract][Full Text] [Related]
19. Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up.
Stan DL; Kim JO; Schaid DJ; Carlson EE; Kim CA; Sinnwell JP; Couch FJ; Vachon CM; Cooke AL; Goldenberg BA; Pruthi S
Cancer Prev Res (Phila); 2024 Feb; 17(2):77-84. PubMed ID: 38154464
[TBL] [Abstract][Full Text] [Related]
20. Polygenic risk score-based prediction of breast cancer risk in Taiwanese women with dense breast using a retrospective cohort study.
Hung CC; Moi SH; Huang HI; Hsiao TH; Huang CC
Sci Rep; 2024 Mar; 14(1):6324. PubMed ID: 38491043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
